Bookmark and Share
Methicillin (CID 6087) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(5)
 
 
Inactive(10)
 
 
Inconclusive(2)
 
 
Unspecified(152)
 
 
Top Targets:
NAD binding 8(1)
 
 
Bcl-2 like(1)
 
 
STKc AGC(1)
 
 
COG2602(1)
 
 
DUF3371(1)
 
 
BioAssay Types:
Literature(127)
 
 
 
 
 
Screening(8)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 169    Data Row: 169   Total Pages: 9   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103179197]
Antibacterial activity against Staphylococcus aureus ATCC 29213 [AID288606, Type: Literature]
View
2
[SID103179197]
Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 [AID288607, Type: Literature]
View
3
[SID48416243]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
4
[SID103179197]
Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by microdilution susceptibility test [AID460794, Type: Literature]
View
5
[SID103179197]
Antibacterial activity against Staphylococcus epidermidis RP62A assessed as growth inhibition after 12 hr by CLSI broth microdilution method [AID1115438, Type: other]
View
6
[SID103179197]
Inhibition of beta-lactamase of Enterobacter aerogenes relative to oxacillin sulfoxide(=1) [AID43270, Type: Literature]Beta-lactamase OXA-9 [gi:166214909]
View
7
[SID103179197]
Antibacterial activity against methicillin-resistant Staphylococcus aureus BAA-44 after 16 to 20 hrs by microdilution susceptibility test [AID460793, Type: Literature]
View
8
[SID103179197]
Antibacterial activity against Staphylococcus aureus by NCCLS method [AID467876, Type: Literature]
View
9
[SID103179197]
Volume of distribution at steady state in human after iv administration [AID540209, Type: Literature]
View
10
[SID103179197]
Clearance in human after iv administration [AID540210, Type: Literature]
View
11
[SID103179197]
Fraction unbound in human after iv administration [AID540211, Type: Literature]
View
12
[SID103179197]
Mean residence time in human after iv administration [AID540212, Type: Literature]
View
13
[SID103179197]
Half life in human after iv administration [AID540213, Type: Literature]
View
14
[SID103179197]
Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 24 hrs by Etest [AID548253, Type: Literature]
View
15
[SID103179197]
Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 24 hrs by Etest [AID548254, Type: Literature]
View
16
[SID103179197]
Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSn mutant gene after 24 hrs by Etest [AID548255, Type: Literature]
View
17
[SID103179197]
Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm mutant gene after 24 hrs by Etest [AID548256, Type: Literature]
View
18
[SID103179197]
Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega expressing vraSm, graRm mutant gene after 24 hrs by Etest [AID548257, Type: Literature]
View
19
[SID103179197]
Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 after 48 hrs by Etest [AID548471, Type: Literature]
View
20
[SID103179197]
Antibacterial activity against vancomycin-susceptible Staphylococcus aureus Mu50omega after 48 hrs by Etest [AID548472, Type: Literature]
View